We are live on
!
Find out more
6CM
683 Capital Management Portfolio holdings
AUM
$1.92B
1-Year Est. Return
85.52%
This Fund
S&P 500
This Quarter
Est. Return
+15.88%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.52B
AUM Growth
+$72.5M
(+5%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-7.32%
Top 10 Holdings %
Top 10 Hldgs %
40.87%
Holding
162
New
22
Increased
37
Reduced
54
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$26.9M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$21.8M |
| 3 |
UWM Holdings
UWMC
|
+$21.1M |
| 4 |
AMTM
Amentum Holdings
AMTM
|
+$12.9M |
| 5 |
Eli Lilly
LLY
|
+$7.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$25.8M |
| 2 |
AllianceBernstein
AB
|
+$20.1M |
| 3 |
HES
Hess
HES
|
+$17.1M |
| 4 |
Baidu
BIDU
|
+$16.3M |
| 5 |
TG Therapeutics
TGTX
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.94% |
| 2 | Consumer Discretionary | 9.33% |
| 3 | Financials | 7.76% |
| 4 | Industrials | 6.88% |
| 5 | Materials | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
PUT
Citigroup
C
$222B
| $8.51M | 0.56% |
+100,000
| New | +$7.23M |
|
52
Gossamer Bio
GOSS
$82.9M
| $7.8M | 0.51% |
6,340,000
+240,000
| +4% | +$262K |
|
53
Madrigal Pharmaceuticals
MDGL
$10.8B
| $7.53M | 0.49% |
24,865
+1,289
| +5% | +$384K |
|
|
APLS
54
DELISTED
Apellis Pharmaceuticals
APLS
| $7.1M | 0.47% |
410,000
+77,000
| +23% | +$1.43M |
|
55
SharkNinja
SN
$22.9B
| $6.93M | 0.46% |
+70,000
| New | +$6.05M |
|
56
Viking Therapeutics
VKTX
$3.7B
| $6.73M | 0.44% |
254,000
-51,000
| -17% | -$1.34M |
|
57
PUT
IonQ
IONQ
$13.6B
| $6.66M | 0.44% |
155,000
+80,000
| +107% | +$2.68M |
|
58
Alphabet (Google) Class A
GOOGL
$4.36T
| $6.34M | 0.42% |
+36,000
| New | +$5.89M |
|
59
Saic
SAIC
$4.95B
| $6.25M | 0.41% |
55,500
+6,500
| +13% | +$741K |
|
60
Amazon
AMZN
$2.92T
| $6.14M | 0.4% |
+28,000
| New | +$5.54M |
|
|
SNDK
61
Sandisk
SNDK
$180B
| $5.99M | 0.39% |
132,000
-8,000
| -6% | -$306K |
|
62
Barnes & Noble Education
BNED
$431M
| $5.73M | 0.38% |
487,000
-28,000
| -5% | -$299K |
|
63
Caesars Entertainment
CZR
$6.06B
| $5.68M | 0.37% |
200,000
-175,000
| -47% | -$4.76M |
|
64
Seadrill
SDRL
$2.8B
| $5.64M | 0.37% |
215,000
+155,000
| +258% | +$3.66M |
|
65
Patria Investments
PAX
$1.75B
| $5.62M | 0.37% |
+400,000
| New | +$4.8M |
|
66
PUT
Lennar Class A
LEN
$19.8B
| $5.53M | 0.36% |
50,000
-25,000
| -33% | -$2.71M |
|
|
FOLD
67
DELISTED
Amicus Therapeutics
FOLD
| $5.5M | 0.36% |
960,000
+685,000
| +249% | +$4.42M |
|
|
PCSC
68
DELISTED
Perceptive Capital Solutions
PCSC
| $5.31M | 0.35% |
500,000
| – | – |
|
69
CACI
CACI
$11B
| $5.24M | 0.34% |
11,000
-500
| -4% | -$222K |
|
|
WLAC
70
DELISTED
Willow Lane Acquisition Corp
WLAC
| $5.12M | 0.34% |
500,000
| – | – |
|
71
PUT
Insmed
INSM
$21.4B
| $4.95M | 0.33% |
+49,200
| New | +$3.76M |
|
72
Sable Offshore Corp
SOC
$1.01B
| $4.95M | 0.32% |
225,000
+94,500
| +72% | +$2.2M |
|
73
British American Tobacco
BTI
$131B
| $4.73M | 0.31% |
100,000
| – | – |
|
74
Builders FirstSource
BLDR
$7.15B
| $4.43M | 0.29% |
+38,000
| New | +$4.38M |
|
75
Geron
GERN
$828M
| $4.37M | 0.29% |
3,100,000
+250,000
| +9% | +$354K |
|
Similar funds
QOP
RIL
MC
RCAG
BOH
DCM
CC
IAN
683 Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, 683 Capital Management held 162 positions worth $1.52B, up 5% from $1.45B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
683 Capital Management withdrew a net $111M in Q2 2025, closing 28 positions and reducing 54 holdings. Its most notable exit was AllianceBernstein, an estimated $20.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, 683 Capital Management opened a new position in Barrick Mining worth $28.6M.
- 683 Capital Management's largest Q2 2025 buy was Barrick Mining: 1,375,000 shares worth $28.6M.
- 683 Capital Management added most to Sarepta Therapeutics in Q2 2025, an estimated $21.8M increase.
- 683 Capital Management's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $25.8M.
- 683 Capital Management fully exited AllianceBernstein in Q2 2025, selling an estimated $20.1M.
- 683 Capital Management's ten largest holdings make up 41% of its $1.52B portfolio in Q2 2025.
- 683 Capital Management opened 22 new positions and closed 28 in Q2 2025.
- 683 Capital Management's portfolio value rose 5% quarter-over-quarter to $1.52B.
Based on 683 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.